About Event
The cell therapy landscape is evolving rapidly, with European developers at the forefront of innovation.
Join us at the 3rd Allogeneic Cell Therapies Summit Europe, the premier event to connect with fellow pioneers shaping the future of off-the-shelf cell therapies.
With investors on the look out for the next big European allogeneic approval, don’t miss out on hearing from the experts who will help you overcome your current challenges and prepare your pipeline for success.
Photos From The Meeting:
Your Peers:
Overcame the challenge of persistence with unique solutions from Cellectis and Smart Immune
Uncovered the secrets to navigating European and global regulations with Chris Bravery
Heard from investment experts from Swarm Oncology and MPC Therapeutics- on what it takes to acquire investment when it comes to European allogeneic research
Scaled your manufacturing processes to seize the full potential of off-the-shelf cell therapies with AdaptImmune and Amniotics
Networked with industry leaders from Adicet Bio and ONK Therapeuticswho are overcoming current challenges for allogeneic therapies and looking to the shining future of this field
Who Your Peers Met:
This summit brought together decision makers, researchers, investors, regulators, and everyone passionate about allogeneic therapies who believe accessible, effective products should be available to those who need them.
Whether a new biotech or an established pharmaceutical giant, the unique insights offered by this conference made it valuable for anyone interested in off-the-shelf therapies.
Previously Attending Companies Include:
What Your Peers Had to Say
